Coenzyme Q10 showdown: new formula may boost absorption
NCT ID NCT06736366
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested how well two different coenzyme Q10 supplements are absorbed into the blood after a single dose. Twenty-five healthy adults aged 50-65 took each product in a crossover design. The goal was to see if a new experimental formula (BMT® coenzyme Q10) leads to higher blood levels than a standard product.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Coenzyme Q10 (ubiquinone) dietary supplement
- What this could lead to
- If one product is absorbed better, it could point to a more effective way to boost coenzyme Q10 levels in people with deficiency.
- What could go wrong
- This is a small, early-stage study in healthy people, not patients. Results may not apply to those with health conditions or long-term use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COENZYME Q DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Primorska, Faculty of Health Sciences
Izola, Municipality of Izola, 6310, Slovenia